Sevoflurane Boston Biopharma

Sevoflurane Boston Biopharma
Product Description

Sevoflurane belongs to a group of medicines called general anesthetics. These work by temporarily reducing the activity of the body’s central nervous system. This causes a complete loss of sensation in the body, including loss of consciousness - allowing surgery to be carried out without pain or distress.

Read more Show less

Boston Biopharma Limited

  • US
  • 2017
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail
Primary activities
Biopharmaceutical
Finished Formulation products Distributor/Buyer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    28523-86-6
More specifications Fewer specifications

Boston Biopharma Limited

  • US
  • 2017
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail
Primary activities
Biopharmaceutical
Finished Formulation products Distributor/Buyer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution
View company profile

More Products from Boston Biopharma Limited (2)

  • Goserelin Boston Biopharma

    Product Goserelin Boston Biopharma

    Goserelin is hormone therapy, classified as "LHRH agonist." (Endocrine Therapy)
    It is indicated:
    - in advanced breast cancer in pre and perimenopausal women suitable for hormonal manipulation
    - as an alternative to chemotherapy in the standard of care for pre and perimenopausal women with estrogen...
  • Bendamustine Boston Biopharma

    Product Bendamustine Boston Biopharma

    Bendamustine is an alkylatic agent used alone (monotherapy) or in combination with other drugs for the treatment of chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer.